Free Republic

A new monoclonal antibody treatment has been found to protect chronically ill adults from developing COVID-19. The Phase 3 trial results suggest the novel antibody cocktail, delivered by intramuscular injection, could offer up to 12 months protection.

In a recorded phone call between a vaccine victim and a representative of Moderna, the rep admitted that everyone that subjects themselves to the vaccine is a participant in the trial.He also admits long-term protective efficacy against Covid-19.The woman on the phone call is suffering from Guillain-Barré syndrome after her first dose and recorded the conversation with this Moderna representaive. https://vidmax.com/video/205736-moderna-rep-admits-during-phone-call-that-everyone-getting-vaccinated-is-part-of-phase-3-of-trails

<p>So begins the typical conversation about an annoying gremlin that has been irritating the New York City Police Department Firearms and Tactics Section (FTS) and Glock, Inc. for approximately six years. When NYPD began experiencing a specific type of malfunction, apparently endemic to the Glock Model 19 service weapon, sometime in 1996, the FTS coined the term "Phase Three" to identify this particular non-reducible stoppage, described as basically a jam where a fired casing is partially extracted, the case rim still solidly lodged under the extractor with the mouth of the casing firmly wedged against the barrel hood. The casing is not vertical in position as in a stovepipe malfunction, but rather horizontal, exactly on the same plane as would be a cartridge loaded in the chamber but higher.</p>